Provision looks back on 2016

Look back at 2016, ahead to the future

By

The year 2016 has been a year of significant progress for Provision, and one that will enable us to aggressively pursue our “mission of developing innovative healthcare solutions focused on improving patient care and clinical outcomes and developing support for research, education and charitable causes.” This year has also been a year which tested our commitment, courage and resolve—and we passed the test.

Here is a summary of some of our key developments… (more…)

Provision reaches 1000-patient milestone!

By

The gong—three clangs that echo through the lobby, treatment rooms, work station cubicles. It’s startling for first-time visitors and new employees.

It quickly becomes the joyous reminder of why we’re here.

Today, the 1000th patient rang the graduation bell to applause of patients, former graduates, employees and supporters of the Provision Center for Proton Therapy. (more…)

Provision grows proton therapy in China

By

China is excited about proton therapy and for good reason.

Officially, 3.5 million Chinese per year are diagnosed with cancer. And 2.2 million people die of cancer, according to the World Health Organization. In the U.S., 70 percent of those with cancer survive five years after treatment. In China, just 30 percent survive to their five-year anniversary. Treatment is hard to come by—there is less than one conventional radiation therapy machine per million people in China compared to more than 12 machines per million in the U.S., for example. And in China diagnosis often happens too late. (more…)

Provision launches research & training center in China

By

On May 122016, Provision Healthcare and Tianjin Taishan Cancer Hospital – International Personalized Cancer Center (IPCC) held the “Tianjin Free Trade Zone Sino-American Proton Therapy International Summit” in Tianjin*. During the summit, Provision and Tianjin IPCC entered into agreement to launch the first international Proton Therapy Clinical Research & Training Center in China. (more…)